A Clinical Trial to Determine the Safety and Immunogenicity of Healthy Candidate (MERS-CoV) Vaccine ChAdOx1 MERS

Condition:   Middle East Respiratory Syndrome Coronavirus Intervention:   Biological: ChAdOx1 MERS Sponsors:   King Abdullah International Medical Research Center;   University of Oxford Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials